These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12969977)

  • 1. Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
    Wang ES; Wu K; Chin AC; Chen-Kiang S; Pongracz K; Gryaznov S; Moore MA
    Blood; 2004 Jan; 103(1):258-66. PubMed ID: 12969977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
    Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
    Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
    Asai A; Oshima Y; Yamamoto Y; Uochi TA; Kusaka H; Akinaga S; Yamashita Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin AC; Harley CB; Gryaznov S
    Cancer Res; 2003 Jul; 63(14):3931-9. PubMed ID: 12873987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
    Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM
    Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
    Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF
    Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agents.
    Gryaznov S; Asai A; Oshima Y; Yamamoto Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin A; Harley C; Akinaga S; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):577-81. PubMed ID: 14565232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
    Shammas MA; Shmookler Reis RJ; Li C; Koley H; Hurley LH; Anderson KC; Munshi NC
    Clin Cancer Res; 2004 Jan; 10(2):770-6. PubMed ID: 14760100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
    Shammas MA; Koley H; Bertheau RC; Neri P; Fulciniti M; Tassone P; Blotta S; Protopopov A; Mitsiades C; Batchu RB; Anderson KC; Chin A; Gryaznov S; Munshi NC
    Leukemia; 2008 Jul; 22(7):1410-8. PubMed ID: 18449204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
    Hashizume R; Ozawa T; Gryaznov SM; Bollen AW; Lamborn KR; Frey WH; Deen DF
    Neuro Oncol; 2008 Apr; 10(2):112-20. PubMed ID: 18287341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells.
    Burchett KM; Yan Y; Ouellette MM
    PLoS One; 2014; 9(1):e85155. PubMed ID: 24409321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
    Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
    Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
    Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
    Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.
    Jackson SR; Zhu CH; Paulson V; Watkins L; Dikmen ZG; Gryaznov SM; Wright WE; Shay JW
    Cancer Res; 2007 Feb; 67(3):1121-9. PubMed ID: 17283146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
    Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
    Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
    Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
    Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of ENA oligonucleotides targeted to human telomerase RNA subunit.
    Horie M; Morita K; Kawakami J; Tsutsumi S; Ando O; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):171-2. PubMed ID: 17150688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.